BPC-157 vs TB-500
§ 01 — Attributes
Summary
A synthetic 15-amino-acid pentadecapeptide derived from a protein in human gastric juice, widely researched for its effects on soft tissue healing, tendon repair, and gut integrity.
A synthetic fragment of the naturally occurring protein thymosin beta-4, used in research for its effects on cell migration, angiogenesis, and tissue repair following injury.
Mechanism
BPC-157 appears to upregulate growth hormone receptor expression, promote angiogenesis through VEGF pathways, and accelerate collagen reorganisation in damaged tissue. Animal models show effects on ligament, tendon, muscle, bone, and gastric mucosa repair.
TB-500 binds to G-actin, regulating actin polymerisation and promoting cell migration to injured tissue. It upregulates VEGF-driven angiogenesis and modulates inflammatory cytokine profiles.
Typical dose
250–500 mcg per day (research protocols)
2–10 mg per week (research protocols)
Half-life
~4 hours (parenteral)
~2–3 days
Administration
Subcutaneous, Intramuscular, Oral (stable form)
Subcutaneous, Intramuscular
Regulatory status
research-only
research-only
Cheapest in stock
£16 · £3.2/mg via Peptides UK
£30 · £6.0/mg via Peptides UK
Offers tracked
2
3